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ABSTRACT 
 
Cardiovascular diseases are primary cause of death worldwide, particularly among 
populations with sedentary lifestyles and diets rich in animal products and processed foods. 
Currently, public health countermeasures to these disorders focus on costly and often 
marginally effective interventions administered only after the development of disease. These 
countermeasures are mainly palliative and fail to address the underlying causes of cardiac 
pathologies. Previously, the authors of the present report have demonstrated that sour cherry 
seed extract (SCSE), a non-toxic low-cost plant material, strongly preserves tissues via 
induction of heme oxygenase-1 (HO-1), a critical host antioxidant defense enzyme. The 
present investigation seeks to characterize underlying mechanisms of SCSE-mediated tissue 
protection. Isolated hearts from Sprague-Dawley rats fed 30 mg/kg/day SCSE for 8 weeks and 
untreated controls were mounted in a “working heart” apparatus and subjected to ischemia 
and reperfusion. A panel of cardiac functional evaluations was conducted on each heart. 
Infarct size assessments were made along with Western blot and immunohistochemical 
analysis for selected proteins involved in cardiovascular homeostasis. SCSE treatment was 
observed to improve post-ischemic cardiac functions and suppress infarct size. Analysis of the 
outcomes produced by the present study is consistent with SCSE cardioprotection that involve 
interaction of Bcl-2 and HO-1. 
Key words: sour cherry seed extract, heme oxygenase-1, ischemia/reperfusion
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INTRODUCTION 
 
The development of improved preventive and therapeutic strategies for ischemic heart 
disease has emerged as a major focus of cardiovascular research during the late 20th and the 
early 21st centuries. Currently, the incidence of the cardiovascular diseases is increasing to 
include progressively younger sectors of the human population, particularly in affluent 
nations (1). Countermeasures to this trend are being actively pursued. During the past several 
years, there has been steady improvement both short- and long-term management of a wide 
range of cardiovascular disorders and associated co-morbidities. Examples of these trends are 
provided in 3 recently published reports, demonstrating impressive gains made in many 
aspects of this field (2-4), underscoring the fast-paced advance of basic and clinical research 
in this field. These outcomes notwithstanding, cardiovascular disease, along with 
obesity/diabetes remain prevalent at epidemic levels in industrialized nations. Thus, programs 
for their management will benefit from adjuvant therapies which may be administered cost-
effectively. For this reason, phytotherapies such as those described here, are particularly 
attractive, due to their low cost, excellent toxicity profiles and long histories of dietary use (5, 
6) 
To support development of phytotherapeutic strategies as contributors to sustainable 
medicine, we have conducted several studies demonstrating significant cytoprotective effects 
of sour cherry seed kernel extract (SCSE). For example, this material has been shown to 
reduce ischemia/reperfusion (I/R)-induced injury in the rat retina via SCSE-mediated 
induction of the endogenous antioxidant enzyme heme oxygenase-1 (HO-1) (7). HO-1 is a 
ubiquitous enzyme widely distributed among animal species and expressed by most tissues. 
Increased activity of HO-1 protects the organism against a diverse variety of stressors (8) and 
pharmacological upregulation of HO-1 is being developed for therapeutic and preventive 
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medical use (9). Previous work by the authors has demonstrated potent cardioprotective 
properties of HO-1 (10, 11). These outcomes are consistent with many investigations 
demonstrating that phytochemical HO-1 induction correlates with improved prognoses of 
many diseases (12).We have previously shown that SCSE strongly protects the heart against 
I/R injury, as revealed by enhanced postischemic left ventricle function, reduced infarct size, 
and decreased apoptosis in rat hearts subjected to I/R-injury (13). Recent animal studies also 
demonstrated SCSE-mediated enhancement of SCSE-mediated adaptive response in hearts of 
hypercholesterolemic rabbits (14). In related in vitro studies, SCSE-induced upregulation of 
HO-1 by human leukocytes, suppressed lipopolysaccharide (LPS)-mediated expansion of 
CD3+TNF-α+ and CD3+IL8+ subpopulations more significantly than in cells from healthy 
individuals in blood from type 2 diabetics (15). The present study was undertaken with the 
objective of characterizing elements of the major mechanisms by which SCSE enhances 
healthy homeostasis and protects cardiovascular tissue. To achieve these goals, isolated 
working hearts from animals treated with SCSE or placebo were evaluated for major 
indicators of cardiovascular homeostasis; and physiological signaling known to affect healthy 
function of these tissues. The major outcome variables assessed following I/R injury as a 
correlate of SCSE treatment included: (i) cardiac functions; (ii) size of infarcted zones (iii) 
expression of proteins related to cell death and survival such as Bcl-2, Akt; (iv) and 
expression of HO-1 in cardiac tissue. 
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MATERIALS AND METHODS 
 
All animals were housed and treated according to the “Principles of Laboratory 
Animal Care” formulated by the National Society for Medical Research, and the “Guide for 
the Care and Use of Laboratory Animals” prepared by the National Academy of Sciences and 
published by the National Institutes of Health (NIH Publication no. 86-23, revised in 1996). 
Maintenance and treatment of animals used in the present study was additionally approved by 
the Institutional Animal Care and Use Committee of the University of Debrecen, Debrecen, 
Hungary. All reagents were obtained from Sigma-Aldrich Co. LLC (Schnelldorf, Germany). 
Sour Cherry Seed Kernel extract was prepared in our laboratory as described previously. 
Briefly, following removal of external shell components, the dried seed kernels were ground 
and extracted with n-hexane, followed by vacuum evaporation and defatting to yield a 
standardized extract suitable for use as a feed supplement (13).  
 
Animals and isolated working heart preparation. 
 
Male 220-280 g Sprague-Dawley rats were fed with commercial food pellets and 
water ad libitum. Animals were segregated into 2 test groups as described: Group 1: Animals 
were treated orally with 30 mg/kg/day SCSE (suspended in 2 % hydroxyethylcellulose 
solution) for a time period of eight weeks; Group 2: Animals in this group received vehicle 
solution (2 % hydroxyethylcellulose solution) for the same time period. 
A representative experimental protocol is summarized as follows: Briefly, following 
8-week treatment regimens with SCSE or vehicle, the rats were anesthetized (ketamine-
xylazine 50/10 mg/kg, ip), and heparinized (1000 IU/kg). Thoracotomy was subsequently 
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performed under terminal anesthesia, followed by excision of hearts and placement of the 
organs in ice-cold modified Krebs-Henseleit buffer, as previously described (13). After the 
thoracotomy, the hearts were cannulated through the aorta and perfused in a Langendorff 
apparatus in “non-working” mode (100 cm H2O) for 5 minutes to cleanly flush blood from 
vessels of the organ. During the Langendorff perfusion, the pulmonary vein was cannulated 
and the preparatum was switched to working mode. After 10 minutes working perfusion, 30 
min global ischemia followed by 120 min reperfusion was initiated. The first 10 minutes 
reperfusion was conducted in Langendorff mode to avoid the fatal ventricular arrhythmias. 
 
Cardiac function assessment.  
 
Baseline parameters for each heart were registered following the 10 minutes working 
perfusion. To examine the recovery of the left ventricle, cardiac function was assessed after 
30, 60, and 120 minutes reperfusion. During the entire experimental procedure, aortic 
pressure (AOP) was measured by computer acquisition system (ADInstruments, PowerLab, 
Castle Hill, Australia). Heart rate (HR) and the first derivative of the aortic pressure 
(AOdP/dt) were calculated from the continuously registered AOP. Coronary flow (CF) was 
measured by the timed collection of the effluent dripping from the heart. Aortic flow (AF) 
was measured using a calibrated flow meter. Cardiac output (CO) was generated as a sum of 
AF and CF. Stroke volume (SV) was calculated as the quotient of CO/HR (16). Decrement of 
SV was calculated as a ratio of SV at reperfusion divided by baseline SV and multiplied by 
100.  
 
Infarct size assessment. 
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The estimations of infarct size were carried out using the triphenyl tetrazolium 
chloride (TTC) method. Briefly, following 30 minutes of ischemia and 120 minutes of 
reperfusion, hearts were perfused with 40 ml 1% (w/v) solution of TTC in phosphate buffer, 
and the samples were stored at -70 °C for subsequent analysis. The frozen samples were 
sectioned, weighted, and blotted dry. The dried sections were scanned on an Epson J232D 
flat-bed scanner. The infarcted area (identifiable by white coloration) and the risk area (entire 
scanned section) were measured using planimetry software (Image J). Estimates of infarcted 
zone magnitude were subsequently obtained by multiplying infarcted areas by weight of each 
slice. The resulting numbers represent weight of the risk zone and the infarcted zone. Infarct 
size was expressed as a ratio of the weight of infarcted tissue and the weight of risk zone 
(whole heart) (13). 
 
Western blot analysis. 
 
Approximately 300 mg of heart tissues were homogenized using a polytron 
homogenizer in isolating buffer (25 mM Tris-HCl, 25 mM NaCl, 1 mM orthovanadate, 10 
mM NaF, 10 mM pyrophosphate, 10 mM okadaic acid, 0.5 mM EDTA, 1 mM PMSF, and 1x 
protease inhibitor cocktail), and centrifuged at 2000 rpm at 4°C for 10 minutes. The 
supernatants were transferred to a new tube and centrifuged at 10,000 rpm at 4°C for 20 
minutes, after which the resulting supernatant was used as cytosolic fraction. The protein 
concentration was measured by a BCA Protein Assay Kit (Thermo Scientific, Rockford, IL, 
USA). 
A total of 50-100 µg of protein in each sample were loaded and resolved using SDS-
PAGE electrophoresis then transferred to a nitrocellulose membrane. After blocking the 
membranes with 5 % nonfat dry milk in TBST, membranes were incubated overnight with 
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primary antibody solution (Bcl-2 1/1000, Akt 1/1000, p-Akt 1/1000, HO-1 1/1000, and 
GAPDH 1/20000 all antibodies were obtained from Cell Signaling Technology, Boston, MA, 
USA) at 4 °C. Subsequently, the membranes were washed in TBST three times and incubated 
with the horseradish peroxidase-conjugated secondary (Cell Signaling Technology, Boston, 
MA, USA) antibody solution containing 1 % nonfat dry milk in TBST for an hour at room 
temperature. After washing, the membranes were treated with Western blot Enhanced 
Chemiluminescent (ECL) HRP substrate (Millipore, Billerica, MA, USA) to visualize the 
bands. Following the ECL treatment, the membranes were exposed on x-ray films (Agfa, 
Mortsel, Belgium). The films were then digitalized and analyzed using ImageJ program. 
 
Immunohistochemistry. 
 
Following reperfusion, the hearts were fixed in 4 % buffered paraformaldehyde 
solution (pH 7.4), embedded in paraffin, and sectioned into 5 µm slices. After deparaffinising 
the sections in xylene, a graded series of alcohol rinses were used to rehydrate the samples. 
Antigen retrieval was accomplished by boiling the slides in 10 mM sodium citrate (pH 6.0) 
containing 0.05 % of Tween 20 for 25 min in a pressure-cooker. H2O2 containing methanol 
was employed for 30 min at room temperature to block endogen peroxidases. Slides were 
then blocked with 5 % FBS in TBST for 1 hour at room temperature. After blocking, the 
slides were washed with TBST and incubated overnight with a primary antibody (Covalab, 
France) diluted in PBST (1/100) at 4 °C. After washing, the slides were incubated with HRP-
conjugated secondary antibody for 1 hour at room temperature (1/300 dilutions). To visualise 
DAB solution (Novolink Polymer Detection System, Leica Biosystems, Newcastle, UK) was 
employed. The slides were then washed and covered with mounting medium. Light 
microscopic images were obtained by a Zeiss Axioscope microscope. 
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Statistical analyses 
Infarct size, HR, CF, AF, LVDP, CO, and SV were expressed as mean values ± SEM. 
The student t-test was performed and a level of p<0.05 was considered statistically 
significant. For Western blot analysis repeated measures of ANOVA followed by Tukey post-
test was accomplished. For statistical analysis we have used the Graphpad Prism software. 
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RESULTS 
Augmentation of post-ischemic left ventricular function by SCSE treatment.  
 
The cardioprotective effect of SCSE treatment was assessed in hearts from rats 
pretreated with the extract for a period of eight weeks. Each heart was subjected to 30 minutes 
of global ischemia and 120 minutes of reperfusion as described above. Figure 1 shows the 
pre- and post-ischemic left ventricular functions to include HR, AF, CF, AOP, AOdP/dt, CO, 
SV and the decrement in SV. Enhanced postischemic ventricular function was observed in the 
SCSE treated group. For example, as shown in Figure 1, after 30 min of ischemia and 120 
min of reperfusion, CO was significantly greater in SCSE-treated hearts with a value of 59.9 ± 
3.4 ml/min than in hearts from vehicle-treated control animals, which exhibited CO values of 
44.2 ± 6.0 ml/min. Similar improvements were noted in measurements of AF, AOP, AOdP/dt 
and decrement in SV in hearts from SCSE-treated animals. Moreover, CO showed a trend, 
albeit non-significant, towards enhancement in the SCSE treated hearts. However, no 
significant difference was observed in HR and CF between groups.  
 
SCSE-mediated effects on infarct size and survival signal. 
 
To further confirm the cardioprotective effect of SCSE, infarct size was measured 
using the TTC method. As shown in Figure 2, the extent of infarction zones in hearts from 
SCSE-treated animals were 11.8 ± 3.6 % which was significantly lower in comparison with 
the vehicle-treated control value of 27.7 ± 4.1 %, further supporting the cardioprotective 
properties of SCSE.  
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Assessment of cell survival signaling in the present study was made via measurements 
of the level of antiapoptotic protein Bcl-2 and the ratio of phosphorylated to non-
phosphorylated Akt (p-Akt/Akt) in cardiac tissue. These experiments were conducted based 
on outcomes of a previous study suggesting that SCSE might modulate these and related 
homeostatic signaling processes (13). The present investigation shows that SCSE treatment 
upregulates Bcl-2 expression in the heart, thereby suppressing apoptosis and inducing the 
survival of the cardiac tissue following I/R challenge (Figure 3 A). Moreover, a non-
significant trend toward enhancement of p-(473)Akt/Akt ratio in SCSE treated hearts was 
noted , but it did not reached the significant level (Fig. 4 B). 
Cell death as a result of I/R injury may occur as a result of both necrotic and apoptotic 
processes. Previous studies demonstrate the ability of plant polyphenols to suppress apoptosis 
and infarct size (17). Results of the present study further validate these outcomes and lend 
additional support for the possibility for use of SCSE in cardioprotection.  
 
SCSE-mediated HO-1 expression. 
 
The authors of the present report have previously demonstrated that SCSE-mediated 
induction of HO-1 in the retina strongly protects against ischemia/reperfusion injury (7). The 
present study measured SCSE dosage effect on HO-1 expression in I/R-injured rat 
myocardium. The results of Western blot analyses shown in Figure 4 reveal elevated HO-1 
protein expression in the myocardium of SCSE-treated rats before, as well as after I/R injury 
in comparison with the vehicle treated control hearts. Consistent with these outcomes, 
immunohistochemical analysis of heart tissue also revealed significantly higher levels of HO-
1 in the SCSE-treated group versus that of the control group (Figure 4). 
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DISCUSSION 
 
Rapid advances made in understanding the pathogenesis of and risk factors of 
cardiovascular diseases during past decades have greatly improved strategies for their long-
term management, however; mortality and morbidity due to these syndromes still provides 
incentive for new directions in research. Moreover, despite clear evidence that prevention of 
cardiovascular disorders is far more cost-effective than therapy after disease develops, high 
risk lifestyle choices remain prevalent in the human population along with increasing 
incidence of heart diseases and related disorders (18, 19)  
The present study demonstrates that administration of SCSE to animals at a dose 
shown in previous work to mediate cardioprotection (13), for a time period double that 
previously used, resulted in superior post-ischemic cardiac function versus drug-free control 
animals (Fig. 1). The outcomes shown in Figure 1 may which demonstrate significant 
improvement in multiple cardiac functions, may have particularly strong relevance to 
development of post-I/R clinical interventions to reduce severity of cardiovascular endothelial 
function.  
In these experiments no sign of any adverse effect of SCSE treatment was observed. It 
is acknowledged that animals in the present study were not specifically monitored for toxic 
effects. However, none was expected based on outcomes of toxicity studies demonstrating 
negligible liver and kidney toxicity of the material in animals, even at dosages in excess of 
therapeutic value (20). Reduction in post-ischemic infarct size was also observed in SCSE-
treated animals (Fig. 3). Moreover, consistent with our previous work, Western blot data 
show the enhanced level of Bcl-2, supporting the antiapoptotic and cyoprotective effect of 
SCSE (Fig. 4 A) (13). Adaptive/protective responses mediated by SCSE have previously been 
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demonstrated to correlate with HO-1 induction as described in studies by the authors showing 
the capacity of SCSE to protect against ischemic damage to both retinal and cardiac tissue (7, 
13). The protective effects of the extract on tissue correlated significantly with elevated HO-1 
protein detected by Western-blotting and immunohistochemistry (7). Studies by other 
investigators have shown that the enzyme may also be induced by common dietary 
phytochemicals (21, 22). Furthermore, transgenic mice expressing high levels of HO-1 exhibit 
reduced susceptibility to I/R-induced damage (10, 11). Additional evidence for the 
cytoprotective effect of phytochemical inducers of HO-1 is provided by a demonstration of 
the ability of chamomile extract-induced HO-1 to protect murine macrophages against 
oxidative stress (23).   
Experiments to determine the effect of SCSE treatment on anti-apoptotic signaling 
were conducted with the objective of providing insight into how the product might be used to 
modulate rates of cell death in cardiac tissue so as to optimize stable tissue homeostasis.   Of 
particular importance to accomplishment of these research goals is identification of how 
redox balance and metabolic energy utilization by cardiomyocytes is altered by I/R injury in 
ways that promote inflammatory tissue damage and remodeling of heart tissue (24-26). 
Examples of such strategies are provided by demonstrations that pharmacological 
interventions which negatively regulate apoptosis – particularly through effect on 
mitochondrial function are cardioprotective following I/R injury (27, 28). A very intriguing 
study of the phenomenon of cardiovascular “necropoptosis” in a guinea pig model 
demonstrated that simultaneous inhibition of necroptosis and apoptosis exhibited additive – 
and possibly synergistic resistance to I/R damage (29). 
An antiapoptotic property of SCSE was suggested by an earlier study by the authors 
(13). The present study reveals increased Bcl-2 levels as a result of SCSE treatment, which 
support the author’s previous findings. Some particularly interesting results have been 
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obtained by examination of the effect of resveratrol, a cytoprotective polyphenol on cardiac 
tissue. This compound was shown to inhibit cardiomyocyte apoptosis induced by doxorubicin 
treatment in lymphoma nude mice (30). The aforementioned study revealed enhanced Bcl-2 
and reduced Bax expression levels in hearts of mice treated with resveratrol before and during 
doxorubicin treatment in comparison with animals treated with doxorubicin alone. The 
protective effect and the modified ratio of Bcl-2/Bax of resveratrol was reversed by zinc 
protoporphyrin IX (HO-1 inhibitor) indicated a correlation of HO-1 and Bcl-2 (30). Our study 
also indicates a HO-1/Bcl-2 axis in the protective effect of SCSE. Additional demonstration 
of the protective effect of HO-1 increased by plant extract induction was observed by the anti-
inflammatory action of genipin, an aglicon of geniposide (31). In this (aforementioned) study, 
the authors demonstrated a PI3-kinase-JNK1/2-Nrf2 cascade as a possible underlying 
mechanism in genipin-induced HO-1 expression. The role of PI3K was also suggested in the 
oleanolic acid-induced HO-1 expression, which contributes to the possible protective effect of 
oleanolic acid in vascular smooth muscle cells (VSMCs) against oxidative stress induced 
cellular damage (32). The study revealed the contribution of the activation of Akt and Erk to 
the Nrf2 nuclear localisation and the subsequent HO-1 induction. The role of Nrf2 in the HO-
1 induction by Ginkgo biloba whole-leaf extract was also reported in VSMCs, and this 
pathway is suggested to play an important role of the anti-atherogenic effect of this plant 
material (33). Based on our results we cannot rule out the additional role of Akt to the 
protective effect of SCSE, but the present study did not confirm an existence of a potential 
HO-1/Akt axis. There were no significant increases in the p-Akt/Akt ratio in hearts from 
SCSE-treated animals. It is nevertheless acknowledged that the present study would have 
benefitted by a more comprehensive evaluation of signalling mechanisms by which SCSE-
mediated increases in HO-1 expression occurred. Of particular interest for ongoing studies of 
this material, are the effects of oxidative stressors, including I/R injury on mitogen-activated 
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protein kinase (MAPK) signaling and activation of the unfolded protein response (UPR). UPR 
activation is observed to upregulate expression of heme oxygenase-1 (HO-1), via the Nrf2 
pathway (34). Since modulation of the UPR has recently been shown to have enormous 
therapeutic potential (35), characterization of how MAPK and critical proteins of the UPR are 
altered by SCSE will yield insight that may result in identification of novel therapeutic targets 
and improved clinical application for the material. 
Limitations of study. 
(a) Applicability of outcomes to human clinical application: The authors acknowledge that 
several major differences between rodent and primate physiology limit the use of these animal 
models in predicting human therapeutic outcomes. Challenges to use of rats in cardiovascular 
research are underscored by three examples major differences between this model and 
humans. One major problem is that pathologies induced in rats using surgery or drugs occur 
rapidly as a consequence of the constraints on timeframe and environmental factors required 
for performance of experiments, whereas the wide-ranging neurohumoral adaptations that 
underlie human cardiovascular disease typically occur over years to decades (36). A second 
confounder to use of the rat model is that whereas heart disease is significantly skewed to 
elderly human populations, most research using rat models typically use young adult animals 
(37). A third problem in use of rat study outcomes as predictors for human therapies is that 
whereas atherosclerosis is a highly significant risk factor for humans and is a major 
contributor to a wide range of cardiovascular syndromes, it is very rare in rats, even in those 
with sustained hyperlipidemia (36). Nevertheless the rat model is widely used in 
cardiovascular research, yielding data that is widely accepted as groundwork for human 
studies when interpreted conservatively. 
(b) Limitation of the model: The model (isolated working heart) of ischemia/reperfusion used 
in the present study possesses limitations: (i) The isolated heart is free from blood and its 
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constituents; moreover, no circulating hormones and transmitters are presented in the 
perfusion buffer, which influence the response of cardiac tissue to ischemia and reperfusion; 
(ii) There is no pre- and afterload during myocardial ischemia. 
(c) Relevance of dosage used in study to therapeutic human dosage: The therapeutic dosage 
of SCSE for rodents of 30 mg/kg/day of extract scaled up to human equivalent is 2.1 grams. 
In caplet form, this would not be practical, however, blended into a “functional food” this 
dosage could be readily delivered in the form of (for instance) a baked good or desert – to 
name only 2 potential configurations. Preliminary human studies suggest that administration 
of large amounts of SCSE may not be required to achieve therapeutic endpoints in humans. 
For example, preliminary human studies with subclinical levels of orally-delivered SCSE 
(250 mg daily, 14 days), demonstrate that low dosage of the extract did not alter the level of 
any toxicity-associated enzymes (unpublished data) and additionally suggest beneficial effects 
of the material on aspects of iron metabolism. These investigations which are ongoing are 
producing data that in time may be cross-referenced with outcomes of animal studies. 
Ultimately, these comparisons will allow reasonable human dose ranges as orally-delivered 
preparations that patients are compliant with, to be selected.  
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Legends for Figures 
 
Figure 1: Effects of sour cherry seed extract treatment on pre- and post-ischemic 
cardiac functions. Left ventricular function was assessed before ischemia and after 30, 60, 
and 120 min of reperfusion. Cardiac functions were recorded by a computer acquisition 
system included: Heart rate (HR); Coronary flow (CF); Aortic flow (AF); Aortic pressure 
(AOP); First derivative of the aortic pressure (AOdP/dt); Stroke volume (SV); and Stroke 
volume decrement in SV. Results are expressed as means ± SEM; n=10 in the control and 
n=14 in the SCSE treated group, * p ˂ 0.05. 
 
Figure 2: Effects of sour cherry seed extract treatment on infarct size. Following I/R, 
TTC-perfused hearts were frozen, sectioned and scanned as described. Infarcted and risk areas 
were assessed by planimetry software ImageJ. Extent of infarct zones were expressed as a 
ratio of infarcted zone and risk zone as a percentage of the weight of the heart shown below as 
the dependent variable in the indicated histograms. Results are expressed as mean ± SEM; 
n=4 in both groups, * p ˂ 0.05. 
 
Figure 3 : Western blot analysis for major biomarker of cardiomyocyte survival. 
Expression of Bcl-2 (Panel A) protein and ratio of p-Akt/Akt levels (Panel B) in rat 
myocardium were measured in homogenized cardiac tissue samples drawn from SCSE or 
vehicle treated hearts in the presence or absence of I/R. C. BL (control baseline): Rats 
receiving no SCSE and no I/R-injury to hearts; C. I/R (control I/R): Rats receiving no SCSE, 
but subjected to I/R; SCSE. BL (SCSE-treated baseline): Rats receiving SCSE, without I/R; 
SCSE. I/R (SCSE-treated I/R,): Rats receiving SCSE and subjected to I/R. GAPDH 
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expression level was measured as a reference protein. Data are expressed as mean ± SEM of 
5-6 different blots. * p ˂ 0.05 
 
Figure 4: Western blot analysis for heme oxygenase-1 protein expression.  
A. Expression of HO-1 protein levels in rat myocardium was measured in homogenized 
cardiac tissue samples drawn from SCSE or vehicle treated hearts in the presence or absence 
of I/R. Abbreviations are described in Fig 3. GAPDH expression level was measured as a 
reference protein. Data are expressed as mean ± SEM of 5-6 different blots. * p ˂ 0.05 
B. Immunohistochemical staining for HO-1 of formalin-fixed 5 µm slices of left ventricular 
tissue from control I/R and SCSE-treated I/R-injured hearts, visualized by light microscopy at 
400x, demonstrating relative HO-1 content in each class of tissue. The brown staining 
indicates the HO-1, a relative lower level was detected in the control I/R samples (panel B left 
side), and an intense brown staining, indicating a higher HO-1 level, was found in the SCSE-
treated I/R samples (panel B, right side) Both image include the negative control in the 
bottom right corner.  
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